Intuitive Surgical (NASDAQ:ISRG) has been assigned a consensus recommendation of “Buy” from the twenty-one brokerages that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, fourteen have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $456.21.
Several analysts have issued reports on the stock. Bank of America upped their price target on shares of Intuitive Surgical from $465.00 to $510.00 and gave the stock a “buy” rating in a research report on Wednesday, April 18th. Vetr lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating and set a $454.14 price target on the stock. in a research report on Tuesday, April 10th. Leerink Swann reaffirmed an “outperform” rating and set a $510.00 price target (up from $475.00) on shares of Intuitive Surgical in a research report on Wednesday, April 18th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical to $430.00 and gave the stock a “sector perform” rating in a research report on Friday, January 26th. Finally, Cantor Fitzgerald increased their price objective on shares of Intuitive Surgical to $510.00 and gave the company an “overweight” rating in a research report on Wednesday, April 18th.
In related news, Director Lonnie M. Smith sold 46,667 shares of the firm’s stock in a transaction that occurred on Friday, April 20th. The shares were sold at an average price of $456.69, for a total value of $21,312,352.23. Following the completion of the transaction, the director now owns 514,137 shares in the company, valued at approximately $234,801,226.53. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Curet Myriam sold 262 shares of the firm’s stock in a transaction that occurred on Tuesday, January 30th. The shares were sold at an average price of $431.50, for a total transaction of $113,053.00. Following the completion of the transaction, the executive vice president now owns 2,152 shares of the company’s stock, valued at approximately $928,588. The disclosure for this sale can be found here. Insiders have sold 207,267 shares of company stock worth $91,140,538 over the last quarter. Corporate insiders own 2.20% of the company’s stock.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Chevy Chase Trust Holdings Inc. increased its stake in shares of Intuitive Surgical by 206.2% in the 4th quarter. Chevy Chase Trust Holdings Inc. now owns 179,792 shares of the medical equipment provider’s stock valued at $65,613,000 after acquiring an additional 121,082 shares in the last quarter. Atria Investments LLC increased its stake in shares of Intuitive Surgical by 189.4% in the 4th quarter. Atria Investments LLC now owns 1,777 shares of the medical equipment provider’s stock valued at $648,000 after acquiring an additional 1,163 shares in the last quarter. Shaker Investments LLC OH grew its position in Intuitive Surgical by 200.0% in the 4th quarter. Shaker Investments LLC OH now owns 2,100 shares of the medical equipment provider’s stock valued at $766,000 after purchasing an additional 1,400 shares during the period. Gulf International Bank UK Ltd grew its position in Intuitive Surgical by 200.0% in the 4th quarter. Gulf International Bank UK Ltd now owns 35,841 shares of the medical equipment provider’s stock valued at $13,079,000 after purchasing an additional 23,894 shares during the period. Finally, LPL Financial LLC grew its position in Intuitive Surgical by 309.0% in the 4th quarter. LPL Financial LLC now owns 16,124 shares of the medical equipment provider’s stock valued at $5,884,000 after purchasing an additional 12,182 shares during the period. Institutional investors and hedge funds own 87.89% of the company’s stock.
ISRG traded down $1.50 during trading hours on Thursday, hitting $446.34. 246,150 shares of the company’s stock were exchanged, compared to its average volume of 880,094. Intuitive Surgical has a 1-year low of $273.48 and a 1-year high of $473.79. The stock has a market capitalization of $51,693.15, a price-to-earnings ratio of 62.29, a PEG ratio of 4.30 and a beta of 0.57.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 17th. The medical equipment provider reported $2.44 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.07 by $0.37. Intuitive Surgical had a net margin of 23.25% and a return on equity of 20.72%. The business had revenue of $848.00 million during the quarter, compared to analysts’ expectations of $773.20 million. During the same quarter in the prior year, the company posted $5.09 earnings per share. The firm’s revenue was up 25.8% on a year-over-year basis. equities research analysts predict that Intuitive Surgical will post 8.84 EPS for the current year.
TRADEMARK VIOLATION WARNING: This story was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/24/intuitive-surgical-isrg-receives-450-80-average-pt-from-analysts.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.